AU695894B2 - Hormonal means for acne therapy and employment thereof - Google Patents

Hormonal means for acne therapy and employment thereof

Info

Publication number
AU695894B2
AU695894B2 AU68408/94A AU6840894A AU695894B2 AU 695894 B2 AU695894 B2 AU 695894B2 AU 68408/94 A AU68408/94 A AU 68408/94A AU 6840894 A AU6840894 A AU 6840894A AU 695894 B2 AU695894 B2 AU 695894B2
Authority
AU
Australia
Prior art keywords
hormonal
hormone
daily units
component
hormone component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU68408/94A
Other versions
AU6840894A (en
Inventor
Marika Ehrlich
Herbert Kuhl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6491735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU695894(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of AU6840894A publication Critical patent/AU6840894A/en
Application granted granted Critical
Publication of AU695894B2 publication Critical patent/AU695894B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

A hormonal agent for the treatment of acne with two spatially separated hormonal components fitted separately in a packaging unit and intended for administration sequentially in time, consisting of a number of hormonal daily units arranged spatially separately in and individually removable from the packaging unit, a first hormonal component essentially containing as the hormonal active agent only an oestrogen preparation causing an increase in the sex hormone-binding globulin (SHBG) and the second hormone component containing an oestrogen and an anti-androgen preparation in combination, characterized in that the total number of daily units is equal to the total number of days in the desired cycle, in that the first hormone component comprises 5 to 14 and the second hormone component 23 to 14 daily units, and in that the number of daily units of the first hormone component is smaller than that of the second hormone component. The invention also concerns the use of this hormonal agent.
AU68408/94A 1993-07-01 1994-06-03 Hormonal means for acne therapy and employment thereof Ceased AU695894B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4321957 1993-07-01
DE4321957A DE4321957C2 (en) 1993-07-01 1993-07-01 Use of a hormonal agent to treat acne
PCT/DE1994/000629 WO1995001180A1 (en) 1993-07-01 1994-06-03 Hormonal agent for the treatment of acne and its use

Publications (2)

Publication Number Publication Date
AU6840894A AU6840894A (en) 1995-01-24
AU695894B2 true AU695894B2 (en) 1998-08-27

Family

ID=6491735

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68408/94A Ceased AU695894B2 (en) 1993-07-01 1994-06-03 Hormonal means for acne therapy and employment thereof

Country Status (14)

Country Link
EP (1) EP0710111B1 (en)
JP (1) JPH09500112A (en)
AT (1) ATE205716T1 (en)
AU (1) AU695894B2 (en)
BR (1) BR9407340A (en)
CA (1) CA2166121A1 (en)
DE (2) DE4321957C2 (en)
DK (1) DK0710111T3 (en)
ES (1) ES2164103T3 (en)
HU (1) HUT73234A (en)
NO (1) NO308586B1 (en)
PT (1) PT710111E (en)
UA (1) UA43337C2 (en)
WO (1) WO1995001180A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19534209A1 (en) * 1995-09-15 1997-03-20 Jenapharm Gmbh Hormonal agent for the treatment of the skin
AU1690399A (en) * 1997-12-26 1999-07-19 Mochida Pharmaceutical Co., Ltd. Neovascularization inhibitor containing dienogest as the active ingredient
DE102004026671A1 (en) 2004-05-28 2005-12-15 Grünenthal GmbH Dosage form for hormonal contraception
DE102004026670A1 (en) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonal contraceptive containing a combination of ethinylestradiol and chlormadinone acetate
DE102004026679A1 (en) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonal contraceptive containing a combination of ethinylestradiol and chlormadinone acetate
DE102006003508A1 (en) * 2006-01-24 2007-07-26 Grünenthal GmbH Use of hormone combination of estrogen from ethinyl estradiol and metabolites of chlormadinone acetate, with chlormadione acetate as gestagen components, for producing medicament e.g. for preventing menstruation cycle-dependent mood
DE102006003509A1 (en) * 2006-01-24 2007-07-26 Grünenthal GmbH Drug delivery system, for hormonal contraception, comprises hormone-containing daily unit, which exhibits estrogen from ethinyl estradiol and estradiol and from metabolite of the chlormadinone acetate optionally with gestagen component

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79447B (en) * 1982-12-31 1984-10-30 Mortimer Christopher H Dr
DE3442857A1 (en) * 1984-11-22 1986-05-22 Schering AG, 1000 Berlin und 4709 Bergkamen Composition for the treatment of androgenisation symptoms in women
DE3916112A1 (en) * 1989-05-16 1990-11-22 Schering Ag DIHYDROSPIRORENONE AS AN ANTIANDROGEN
DE4104385C1 (en) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
PT710111E (en) 2002-02-28
NO308586B1 (en) 2000-10-02
AU6840894A (en) 1995-01-24
JPH09500112A (en) 1997-01-07
WO1995001180A1 (en) 1995-01-12
CA2166121A1 (en) 1995-01-12
DK0710111T3 (en) 2001-12-10
HU9503770D0 (en) 1996-02-28
NO955347L (en) 1995-12-29
ATE205716T1 (en) 2001-10-15
DE4321957A1 (en) 1995-01-12
BR9407340A (en) 1996-10-08
UA43337C2 (en) 2001-12-17
DE59409869D1 (en) 2001-10-25
EP0710111B1 (en) 2001-09-19
NO955347D0 (en) 1995-12-29
EP0710111A1 (en) 1996-05-08
ES2164103T3 (en) 2002-02-16
HUT73234A (en) 1996-07-29
DE4321957C2 (en) 1995-09-28

Similar Documents

Publication Publication Date Title
AU1062595A (en) Means and method for hormonal contraception and/or acne treatment
DE69432752D1 (en) COMPOSITION FOR SUBSTITUTION THERAPY THAT CONTAINS AT LEAST ONE PROGESTOGEN AND AT LEAST ONE OESTROGEN
CA2045885A1 (en) Inhibition of mammalian muscle wasting and protein degradation by tetracyclines
NZ308293A (en) Antibacterial-wound healing compositions comprising a pyruvate, antioxidant and fatty acids
TW429152B (en) A tretinoin aqueous gel composition for therapeutic topical administration to the skin
AU1537095A (en) Therapeutic agents containing thyroid hormones
AU1255002A (en) Delayed-release pharmaceutical formulations
MX9703354A (en) Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids.
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
AU609664B1 (en) A method of treating premature ejaculation using sertraline
UA41401C2 (en) Pharmaceutical combined contraceptive agent
HK1029738A1 (en) A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor.
EP0663835A1 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.
AU695894B2 (en) Hormonal means for acne therapy and employment thereof
WO1994002103A3 (en) Ovulation inhibitor for hormonal contraception
AU1191795A (en) Deuterated active substances in transdermal application
GR3023828T3 (en) Compositions for treatment of the hair.
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
HUP0100634A2 (en) Pharmaceutical preparations comprising pentaerytritol tetranitrate
MX9709684A (en) Use of vitamin d4 derivatives for treating skin disorders.
UA19504A (en) Agent for treatment of the skin and hypodermic cellular tissue purulent inflammations
MX9800697A (en) Use of calendula glycosides for the treatment of psoriasis.

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired